Vascular Therapies, Inc.
Clinical trials sponsored by Vascular Therapies, Inc., explained in plain language.
-
New implant aims to fix a major problem for kidney patients
Disease control CompletedThis study tested a small, drug-releasing implant placed during surgery to create a dialysis access point (called a fistula). The goal was to see if the implant, compared to standard surgery, could help the fistula develop better and last longer for patients on kidney dialysis. A…
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New implant aims to make kidney dialysis access more reliable
Disease control CompletedThis study tested whether a small, drug-releasing implant placed during surgery could improve the success of creating a usable dialysis access point (called a fistula) in the arm. It involved 269 people with kidney failure who needed to start or were recently on dialysis. Researc…
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC